| 
  • If you are citizen of an European Union member nation, you may not use this service unless you are at least 16 years old.

  • Stop wasting time looking for files and revisions. Connect your Gmail, DriveDropbox, and Slack accounts and in less than 2 minutes, Dokkio will automatically organize all your file attachments. Learn more and claim your free account.

View
 

E-Portfolio

Page history last edited by Prof. Dr. W.W. van den Broek 9 years, 4 months ago

Recent activities

 

Lecture on ECT for lay public on the Publieksdag in honor of the 140th birthday of the Dutch Association of Psychiatry

 

Yearly theoretical course on ECT during the annual conference of the Dutch Association of Psychiatry in Amsterdam on March 30th 2011, technical aspects of ECT

 

Invitational conference ECT march 24, 2011.  Organized by the Dutch Workingroup on ECT (WEN). Audit model ECT, the motivation for this ausit model: my presentation

 

Interview about Electro convulsive therapy in "Vrij Nederland", a Dutch magazine, on November 20th 2010.  
 

Successfully became Kern Docent at the Erasmus MC on 15th of October 2010.

Course on Information Trapping voor psychiatrists (Bijblijven met Internet) on the yearly conference of the Dutch Association of Psychiatry in Maastricht (2010)

 

ECT course for psychiatrists and residents on the yearly conference of the Dutch Association of Psychiatry in Maastricht (2010), The Netherlands. Slides

 

Since 1-1-2010 head of the department of psychiatry ad interim at the Erasmus MC. Director of psychiatric residency training, Director of psychiatric medical education, Medical Superintendent (geneesheer-directeur).

 

Attended the course: Editing medical journals - short course. The course was held in Oxford, November 18-20 2009.

This two-day course, now in its eleventh year, looks at the knowledge, skills and attitudes needed to run a successful publication.

By the end of the course participants will be able to…

1. understand the roles of editor in relation to the journal owner/publisher, their authors, and the public 

2. identify strategies for succeeding in print and electronic publishing, 

3. use a range of techniques to increase the chances of the journal being read and understood, 

4. set up copy flow and reviewing systems that will meet the needs of journal, authors and readers, 

5. apply a range of techniques to attract - and keep - high calibre authors, 

6. understand and meet ethical responsibilities to a number of different publics, 

7. have a clear action plan for the coming year.

 

Since september 2008 editor of the Dutch/Flemish Journal of Psychiatry, and also contributor on Twitter for the journal

 

Recent interview in Dutch national newspaper: De Volkskrant about the new ECT guidelines.

 

Recent interview about Electroconvuslive therapy in Psy, here is the PDF in Dutch.

 

 

The book: Electroconvulsive and Neuromodulation Therapies edited by Conrad M. Swartz is out. Contributed Electroconvulsive therapy in continental Western Europe with Pascal Sienaert MD, psychiatrist, University Psychiatric Center-Catholic University Leuven (campus Kortenberg) from Belgium and Postelectroconvulsive therapy evaluation and prophylaxis together with Tom K. Birkenhager MD PhD, psychiatrist, Erasmus MC Rotterdam The Netherlands.

 

Attended 3 workshops on Verhalen in wetenschap en onderwijs  and 3 workshops on Onderwijs en de techniek van het theater by RISBO

 

ECT course for psychiatrists and residents on the yearly conference of the Dutch Association of Psychiatry in Groningen, The Netherlands. Slides

 

Lecture about ECT for Nationaal Anesthesiecongres from Nederlandse Vereniging van Anesthesiemedewerkers on January 17th 2009.

 

Interview in Psy about the use of social media and physicians, here is the PDF in Dutch.

 

Interview about my blog: Dr Shock MD PhD in Medisch Contact March 2008.

 

Training:

1978-1985     Medical study at the Medical Faculty, Rijksuniversiteit Leiden

1985-1988     Resident for Riagg Noordhage, The Hague

1988-1992     Residency in psychiatry, Erasmus Medical Centre Rotterdam

April 1992     Certification as psychiatrist

 

Doctorate:

16 June 2004    Dissertation on “Treatment of depressed inpatients, efficacy and tolerability of a four step treatment algorithm” at the Erasmus University Rotterdam.

 

Working experience since graduating:

Since 2004    Associate professor in psychiatry, and deputy director of psychiatric residency training, dept. of psychiatry, Erasmus MC, Rotterdam.

 

Working experience:

1999-2004    Head of the depression unit of the department of psychiatry, Erasmus MC, Rotterdam.

1992-1999    Psychiatrist, depression unit of the dept. Of psychiatry, Erasmus MC Rotterdam.

1985-1987    Resident, department of social psychiatry, The Hague.

 

Further professional experiences

In the field of medical and psychiatric education and research:

Since 1988 I taught nurses, medical students and residents, and I have extensive experience in medical and psychiatric education, training and supervision. I am a member of many educational committees and participated in the development of different educational programs for medical students and psychiatric residents. I supervised many medical students doing their medical traineeship. I trained many residents and psychiatrists in the theoretical and practical aspects of Electroconvulsive therapy. Furthermore I was a member of different review dissertation committees and acted as opponent.

 

In the field of psychiatric administration:

Since 1995 I have been a member of professional committees of the Netherlands Psychiatric Association including the Section Consultation- and Liaison Psychiatry and

the Scientific Committee. Founder and secretary of the Dutch Workgroup for Electroconvulsive therapy. Under auspices of the Netherlands Psychiatric Association, in 2000 the Practice guideline Electroconvulsive therapy was published, of which steering group I was the chairman.

 

Editorial board of scientific journals:

2005    Current Drug Therapy

 

Publications

van Waarde JA, Verwey B, van den Broek WW, van der Mast RC. Electroconvulsive Therapy in the Netherlands: A Questionnaire Survey onContemporary Practice.

J ECT. 2009 Jan 31. 

Heijnen W, van den Broek W, Mulder P, Birkenhäger T. Prevalence of trait anxiety in a sample of depressed inpatients and its influenceon response to antidepressants.

J Psychopharmacol. 2008 Nov 21. 

Heijnen WT, van den Broek WW, Birkenhäger TK. Treatment failure with a tricyclic antidepressant followed by lithium addition and response to subsequent electroconvulsive therapy. J Clin Psychiatry. 2008 Dec;69(12):1887-91. 

van den Broek WW, Mulder PG, van Os E, Birkenhäger TK, Pluijms E, Bruijn JA. Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis.J Psychopharmacol. 2008 Jun 26. 

Birkenhager TK, van den Broek WW, Mulder PG, Moleman P, Bruijn JA. Efficacy of imipramine in psychotic versus nonpsychotic depression.

J Clin Psychopharmacol. 2008 Apr;28(2):166-70.

Schat A, van den Broek WW, Mulder PG, Birkenhäger TK, van Tuijl R, Murre JM. Changes in everyday and semantic memory function after electroconvulsive therapy 

for unipolar depression.J ECT. 2007 Sep;23(3):153-7.

Birkenhäger TK, van den Broek WW, Fekkes D, Mulder PG, Moleman P, Bruijn JA. Lithium addition in antidepressant-resistant depression: effects on platelet

5-HT, plasma 5-HT and plasma 5-HIAA concentration. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1084-8.

van Beusekom BS, van den Broek WW, Birkenhäger TK. Long-term follow-up after successful electroconvulsive therapy for depression: a 4- to 8-year naturalistic follow-up study.J ECT. 2007 Mar;23(1):17-20.

van den Broek WW, Birkenhäger TK, Mulder PG, Mathot RA, Bruijn JA, Moleman P. Time-dependent clearance decrements of fluvoxamine in depressed inpatients: a

clinical evaluation.J Clin Psychopharmacol. 2007 Apr;27(2):231-3.

van Os E, van den Broek WW, Mulder PG, ter Borg PC, Bruijn JA, van Buuren HR. Depression in patients with primary biliary cirrhosis and primary sclerosing

cholangitis.J Hepatol. 2007 Jun;46(6):1099-103.

Nolen WA, van den Broek WW, Birkenhäger TK. Treatment with low doses of tranylcypromine resulted in a disappointing remission rate.

Am J Psychiatry. 2007 Mar;164(3):524; author reply 524.

Tulen JH, Volkers AC, van den Broek WW, Bruijn JA. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in

antidepressant-refractory depression.J Clin Psychopharmacol. 2006 Oct;26(5):542-4.

Birkenhäger TK, van den Broek WW, Moleman P, Bruijn JA. Outcome of a 4-step treatment algorithm for depressed inpatients.J Clin Psychiatry. 2006 Aug;67(8):1266-71.

van den Broek WW, Birkenhäger TK, Mulder PG, Bruijn JA, Moleman P. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed

inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.J Clin Psychiatry. 2006 Feb;67(2):263-8.

Pluijms EM, Birkenhäger TK, Mulder PG, van den Broek WW. Influence of episode duration of major depressive disorder on response to

electroconvulsive therapy.J Affect Disord. 2006 Feb;90(2-3):233-7.

Birkenhäger TK, van den Broek WW, Mulder PG, de Lely A. One-year outcome of psychotic depression after successful electroconvulsive

therapy.J ECT. 2005 Dec;21(4):221-6.

Ju MR, Birkenhager TK, van den Broek WW. Does power matter with ECT? J Affect Disord 2005.

Birkenhager TK, van den Broek WW, Moleman P, Vulto AG, Bruijn JA. Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed? Psychopharmacology (Berl) 2005;181(3):595-9.

Birkenhager TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients. J Clin Psychiatry 2004;65(11):1505-10.

Birkenhager TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P. Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder. Am J Psychiatry 2004;161(11):2060-5.

ter Borg PC, van Os E, van den Broek WW, Hansen BE, van Buuren HR. Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]. BMC Gastroenterol 2004;4:13.

van den Broek WW, Birkenhager TK, Mulder PG, Bruijn JA, Moleman P. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. Psychopharmacology (Berl) 2004;175(4):481-6.

van den Broek WW, de Lely A, Mulder PG, Birkenhager TK, Bruijn JA. Effect of antidepressant medication resistance on short-term response to electroconvulsive therapy. J Clin Psychopharmacol 2004;24(4):400-3.

van den Broek WW, Groenland TH, Kusuma A, Mulder PG, Bruijn JA. Double-blind placebo controlled study of the effects of etomidate-alfentanil anesthesia in electroconvulsive therapy. J Ect 2004;20(2):107-11.

Volkers AC, Tulen JH, van den Broek WW, Bruyn JA, Passchier J, Pepplinkhuizen L. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. Pharmacopsychiatry 2004;37(1):18-25.

Volkers AC, Tulen JH, van den Broek WW, Bruijn JA, Passchier J, Pepplinkhuizen L. Motor activity and autonomic cardiac functioning in major depressive disorder. J Affect Disord 2003;76(1-3):23-30.   

Otte W, Birkenhager TK, van den Broek WW. Fatal interaction between tranylcypromine and imipramine. Eur Psychiatry 2003;18(5):264-5.

van den Broek WW, Groenland TH, Kusuma A, Mulder PG, Bruijn JA. Alfentanil has no proconvulsive effect during electroconvulsive therapy. Can J Anaesth 2003;50(2):198-9.

Koetsier GC, Volkers AC, Tulen JH, Passchier J, van den Broek WW, Bruijn JA. CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine. J Psychiatr Res 2002;36(6):391-7.

Volkers AC, Tulen JH, Van Den Broek WW, Bruijn JA, Passchier J, Pepplinkhuizen L. 24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder. Eur Neuropsychopharmacol 2002;12(4):273-8.

Volkers AC, Tulen JH, Duivenvoorden HJ, Gieteling MJ, Wegewijs-De Jong M, Van Den Broek WW, et al. Effect of personality dimensions on the diurnal pattern of motor activity. J Pers Disorders 2002;70(2):233-47.

Bruijn JA, Moleman P, van den Broek WW, Mulder PG. Trait anxiety and the effect of a single high dose of diazepam in unipolar depression. J Psychiatr Res 2001;35(6):331-7.

Bruijn JA, Moleman P, Mulder PG, van den Broek WW. Treatment of mood-congruent psychotic depression with imipramine. J Affect Disord 2001;66(2-3):165-74.

Hoekstra R, van den Broek WW, Fekkes D, Bruijn JA, Mulder PG, Pepplinkhuizen L. Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression. Psychiatry Res 2001;103(2-3):115-23.

van der Mast RC, van den Broek WW, Fekkes D, Pepplinkhuizen L, Habbema JD. Is delirium after cardiac surgery related to plasma amino acids and physical condition? J Neuropsychiatry Clin Neurosci 2000;12(1):57-63.

van den Broek WW, Leentjens AF, Mulder PG, Kusuma A, Bruijn JA. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study. Br J Anaesth 1999;83(2):271-4.

Bruijn JA, Moleman P, Mulder PG, van den Broek WW. Depressed in-patients respond differently to imipramine and mirtazapine. Pharmacopsychiatry 1999;32(3):87-92.

van der Mast RC, van den Broek WW, Fekkes D, Pepplinkhuizen L, Habbema JD. Incidence of and preoperative predictors for delirium after cardiac surgery. J Psychosom Res 1999;46(5):479-83.

Bruijn JA, Moleman P, Mulder PG, van den Broek WW. Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition. J Clin Psychiatry 1998;59(12):657-63.

Leentjens AF, van den Broek WW, Kusuma A, Bruijn JA. Facilitation of ECT by intravenous administration of theophylline. Convuls Ther 1996;12(4):232-7.

Bruijn JA, Moleman P, Mulder PG, van den Broek WW, van Hulst AM, van der Mast RC, et al. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacology (Berl) 1996;127(3):231-7.

van der Mast RC, van den Broek WW, Fekkes D, Pepplinkhuizen L, Roest FH. Delirium after cardiac surgery. The possible role of tryptophan in relation to the other neutral aminoacids. Adv Exp Med Biol 1996;398:93-6.

Trijsburg RW, Jelicic M, van den Broek WW, Plekker AE, Verheij R, Passchier J. Exposure and participant modelling in a case of injection phobia. Psychother Psychosom 1996;65(1):57-61.

 

 

National Publications

van den Broek WW. [The practice guideline 'Depressive disorder' (first revision) from the Dutch College of General Practitioners; a response from the perspective of psychiatry]. Ned Tijdschr Geneeskd 2005;149(10):509-10.

Gieteling M, Hoekstra R, van den Broek WW, Bruijn JA. [A successful treatment of drug-resistant depression with electroconvulsive therapy]. Ned Tijdschr Geneeskd 1998;142(38):2110-2.

Naarding P, van den Broek WW, Koudstaal PJ. [Cerebrovascular lesions and depression]. Tijdschr Gerontol Geriatr 1997;28(6):254-9.

Lemstra A, Leentjens AF, van den Broek WW. [Temporary results only in electroconvulsive therapy in therapy-resistant depression; retrospective study]. Ned Tijdschr Geneeskd 1996;140(5):260-4.

Leentjens AF, van den Broek WW, Birkenhager TK, Moleman P, Bruijn JA. [Effect of adjuvant drug therapy following successful electroconvulsive therapy for therapy-resistant depression is still disappointing]. Ned Tijdschr Geneeskd 1996;140(5):241-3.

Naarding P, van den Broek WW, Bruijn JA, Moleman P. [Addition of lithium to medication in depressive patient resistant to treatment with tricyclic antidepressive agents]. Ned Tijdschr Geneeskd 1995;139(11):574-7.

Dieleman BP, van den Broek WW, van de Wetering BJ. [The suppressed medication with far-reaching consequences]. Ned Tijdschr Geneeskd 1992;136(7):335-6.

van der Mast RC, van den Broek WM, Moleman P. [A psychiatric disorder in an intensive care unit]. Ned Tijdschr Geneeskd 1991;135(32):1460.

Dieleman BP, van den Broek WW, van de Wetering BJ. [Abuse of anticholinergic agents]. Ned Tijdschr Geneeskd 1990;134(13):625-7.

van den Broek WW, van Hulst AM, Klompenhouwer JL, Moleman P. [Lasting neurological damage with therapeutic plasma lithium levels]. Ned Tijdschr Geneeskd 1988;132(45):2063-6.

Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P. Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition. Tijdschr Psychiatr. 2006;48(4):271-81.

van den Broek WW, Birkenhäger TK, Pluijms EM. Reaction to 'Is it advisable to combine electroconvulsive therapy (ECT) with psychotropics?'

Tijdschr Psychiatr. 2008;50(4):243-4; author reply 244-5.

van den Broek WW, Groenland TH, Mulder PG, Kusuma A, Birkenhäger TK, Pluijms EM, Bruijn JA. Beta-blockers and electroconvulsive therapy: a review]

Tijdschr Psychiatr. 2008;50(4):205-15.

 

 

Books, or contribution to books

van den Broek WW,Leentjens AFG, Verwey B. Elektroconvulsietherapie. Houten/Diegem: Bohn Stafleu van Loghum, 1999.

van den Broek WW, Leentjens AFG, van Vliet IM, Verwey B. Handboek Elektroconvulsietherapie. Assen: Koninklijke van Gorcum, 2005

 

Comments (0)

You don't have permission to comment on this page.